<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108527-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Conception sur mesure de vaccins nanoparticulaires &#xE0; multicomposant pour la fi&#xE8;vre de la c&#xF4;te M&#xE9;diterran&#xE9;e</narrative>
   <narrative xml:lang="EN">Custom design of multi-component nanoparticle vaccines for East Coast fever</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">East Coast fever (ECF), a leukemia-like tick-borne disease of cattle, is caused by the protozoan blood parasite Theileria parva. ECF is a leading cause of cattle mortality in most of sub-Saharan Africa. The acute and fatal nature of the disease poses major challenges to disease control. Treatment of ECF, or prevention by use of poisons to reduce tick infestation, are expensive and rarely accessible to poor farmers. A live vaccine involving administration of tick-derived parasites and simultaneous antibiotic treatment has been available for over 40 years, but is difficult to produce and distribute as it requires high technical expertise and storage and transport in liquid nitrogen (-80&#x2DA;C). These drawbacks have hampered the widespread use of this vaccine and the disease has continued to have a devastating impact on poor smallholder farmers.

The objective of this project is to reformulate the partially-protective major sporozoite antigen p67 of Theileria parva into a nanoparticle that generates high antibody levels and better vaccine efficacy. Using a cutting-edge computation protein nanoparticle platform, different configurations of nanoparticles will be produced to test the best options to co-display multiple copies of key components of the p67 antigen. In addition, two immunomodulatory proteins will be incorporated to enhance the quality and duration of immunity. The best nanoparticle combinations of the p67 antigen and immunomodulatory proteins will be tested in a disease-challenge study in cattle. This will enable the development of a viable vaccine candidate that can be produced commercially in a potential second phase of this project.

This project is a collaboration between the University of Washington and the International Livestock Research Institute. The team will also collaborate with scientists from the University of Copenhagen, University of Toronto, and Atreca Inc. (a private US biotechnology company). This project is funded through the Livestock Vaccine Innovation Fund, a partnership between the Bill and Melinda Gates Foundation, Global Affairs Canada, and IDRC. 

The Livestock Vaccine Innovation Fund is a partnership of the Bill and Melinda Gates Foundation, Global Affairs Canada, and IDRC. It represents a joint investment of CA$57 million over five years to support the development, production, and commercialization of innovative vaccines against priority livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia.</narrative>
   <narrative xml:lang="FR">La fi&#xE8;vre de la c&#xF4;te M&#xE9;diterran&#xE9;e (FCM) est une maladie transmise par les tiques, qui touche les bovins et qui est caus&#xE9;e par le protozoaire Theileria parva. La FCM est la principale cause de mortalit&#xE9; chez les bovins en Afrique subsaharienne. Le traitement de la FCM et la pr&#xE9;vention au moyen de poisons servant &#xE0; r&#xE9;duire l&#x2019;infestation de tiques sont on&#xE9;reux et rarement abordables. Il existe depuis plus de 40 ans un vaccin vivant comportant l&#x2019;administration de parasites d&#xE9;riv&#xE9;s des tiques et un traitement antibiotique simultan&#xE9;, mais il est difficile &#xE0; produire et &#xE0; distribuer. Ces inconv&#xE9;nients ont emp&#xEA;ch&#xE9; l&#x2019;utilisation r&#xE9;pandue de ce vaccin et la maladie a continu&#xE9; &#xE0; avoir un effet d&#xE9;vastateur sur les petits exploitants agricoles pauvres.

Ce projet vise &#xE0; reformuler le principal antig&#xE8;ne sporozoite p67 du protozoaire Theileria parva, qui est partiellement protecteur, en une nanoparticule qui produit des niveaux &#xE9;lev&#xE9;s d&#x2019;anticorps et un vaccin plus efficace. Au moyen d&#x2019;une plateforme de pointe de calcul des nanoparticules prot&#xE9;iques, on pourra produire diff&#xE9;rentes configurations de nanoparticules afin de trouver les meilleures options pour afficher des copies multiples des composants cl&#xE9;s de l&#x2019;antig&#xE8;ne p67. De plus, deux prot&#xE9;ines immunomodulatoires y seront incorpor&#xE9;es dans le but d&#x2019;am&#xE9;liorer la qualit&#xE9; et la dur&#xE9;e de l&#x2019;immunit&#xE9;. Les meilleures combinaisons de nanoparticules de l&#x2019;antig&#xE8;ne p67 et des prot&#xE9;ines immunomodulatoires seront analys&#xE9;es dans une &#xE9;tude de cas-t&#xE9;moin aupr&#xE8;s du b&#xE9;tail. Cela permettra le d&#xE9;veloppement d&#x2019;un candidat vaccin viable qui peut &#xEA;tre produit &#xE0; l&#x2019;&#xE9;chelle commerciale dans une &#xE9;ventuelle seconde phase du projet.

Ce projet d&#xE9;coule d&#x2019;une collaboration entre l&#x2019;Universit&#xE9; de Washington et l&#x2019;Institut international de recherche sur l&#x2019;&#xE9;levage. L&#x2019;&#xE9;quipe collaborera avec des scientifiques de l&#x2019;Universit&#xE9; de Copenhague, l&#x2019;Universit&#xE9; de Toronto et Atreca Inc. (une soci&#xE9;t&#xE9; de biotechnologie am&#xE9;ricaine priv&#xE9;e). Ce projet est financ&#xE9; gr&#xE2;ce au Fonds d&#x2019;innovation en vaccins pour le b&#xE9;tail (FIVB), un partenariat entre la Fondation Bill et Melinda Gates, Affaires mondiales Canada et le CRDI. 

Le Fonds d&#x2019;innovation en vaccins pour le b&#xE9;tail (FIVB) est un partenariat entre la Fondation Bill et Melinda Gates, Affaires mondiales Canada et le CRDI. Il repr&#xE9;sente un investissement conjoint de 57 millions CAD sur cinq ans afin de financer le d&#xE9;veloppement, la production et la commercialisation de vaccins innovants contre les maladies du b&#xE9;tail prioritaires en Afrique subsaharienne, en Asie du Sud et en Asie du Sud-est.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
   <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="80">
   <narrative xml:lang="EN">University of Washington</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">University of Washington</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2017-06-15" type="2"></activity-date>
  <activity-date iso-date="2019-11-12" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="KE" percentage="100"></recipient-country>
  <sector code="2" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Increasing food security</narrative>
   <narrative xml:lang="FR">S&#xE9;curit&#xE9; alimentaire</narrative>
  </sector>
  <sector code="31195" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-08-22"></transaction-date>
   <value currency="CAD" value-date="2017-08-22">349772.31</value>
   <provider-org>
    <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-08-22"></transaction-date>
   <value currency="CAD" value-date="2017-08-22">349772.31</value>
   <provider-org>
    <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-08-22"></transaction-date>
   <value currency="CAD" value-date="2017-08-22">181525.64</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
    <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-08-22"></transaction-date>
   <value currency="CAD" value-date="2017-08-22">181525.64</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
    <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-08-22"></transaction-date>
   <value currency="CAD" value-date="2017-08-22">130102.05</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-08-22"></transaction-date>
   <value currency="CAD" value-date="2017-08-22">130102.05</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-08-23"></transaction-date>
   <value currency="CAD" value-date="2017-08-23">19515</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-08-23"></transaction-date>
   <value currency="CAD" value-date="2017-08-23">27228</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-08-23"></transaction-date>
   <value currency="CAD" value-date="2017-08-23">52465</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-03-31"></transaction-date>
   <value currency="CAD" value-date="2018-03-31">129929</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-03-31"></transaction-date>
   <value currency="CAD" value-date="2018-03-31">48328</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-03-31"></transaction-date>
   <value currency="CAD" value-date="2018-03-31">67431</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-10-15"></transaction-date>
   <value currency="CAD" value-date="2019-10-15">167376</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-10-15"></transaction-date>
   <value currency="CAD" value-date="2019-10-15">62257</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-10-15"></transaction-date>
   <value currency="CAD" value-date="2019-10-15">86865</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-130102</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-181525</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-349772</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">130102</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">181525</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">349772</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Washington</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
